High-purity biological defense for Oman's expanding livestock sectors.
Broad-spectrum antiparasitic solution optimized for arid environmental conditions.
Advanced formulation ensuring animal health and regulatory compliance.
Rapid-absorption formula for large-scale systemic infection treatment.
As the Sultanate of Oman pivots towards its Vision 2040, the pharmaceutical and biotechnology sectors have been identified as critical pillars for economic diversification and national security. At Jiangxi Serum Pharma Industries Co., Ltd., we recognize the unique requirements of the Omani market—from the high thermal stability required for medicine storage in Al Batinah to the stringent regulatory compliance managed by the Ministry of Health (MoH).
Our decade-long expertise as a primary supplier of pharmaceutical intermediates, biological products, and medical consumables positions us as a bridge between world-class manufacturing and local Omani distribution needs.
Oman is rapidly transforming from a net importer to a regional hub for pharmaceutical manufacturing. With special economic zones like Salalah Free Zone and SOHAR Port and Freezone, the demand for high-quality raw materials (APIs) and intermediates is surging. Serum Pharma provides the essential building blocks for local Omani labs to produce affordable, high-quality generics.
The Directorate General of Pharmaceutical Affairs and Drug Control (DGPA & DC) in Oman maintains rigorous standards. Our products are manufactured in WHO-GMP certified facilities, ensuring that every batch of vaccine or Western medicine imported into Muscat meets the Sultanate’s Pharmacopoeia standards.
The future of Omani pharma lies in specialization. We are currently implementing a technical roadmap that focuses on Co-Crystallization and Bio-Fermentation. These technologies allow for better bioavailability of drugs, crucial for treating chronic conditions in the Gulf region.
Recent analysis indicates a significant shift in the Middle East toward Plant-derived Squalene and plant extracts. These are increasingly used in Oman's dermatological and nutritional sectors. Our commitment to sourcing from nature ensures high purity for Omani consumers seeking organic health alternatives.
With metabolic health becoming a priority in the GCC, our focus on the GLP-1 pathway and small-molecule oral drug research aligns with the latest FDA approvals. We support Omani healthcare providers by offering insights into the fastest-growing therapeutic categories globally.
Operating in Oman requires more than just high-quality products; it requires a deep understanding of the Omani Customs Law and the specific clearance procedures at Muscat International Airport and Port Sultan Qaboos.
We use high-grade thermal insulation and real-time GPS temperature monitoring for all sensitive shipments to Muscat, ensuring no thermal degradation occurs during transit.
We provide all necessary documentation (GMP, COA, Dossiers) required for local Omani partners to facilitate MoH registration and drug control approval.
Yes, we specialize in customizing nutritional and medical pre-mixes tailored to the specific dietary and health challenges of livestock in the Arab Peninsula.
MOQs vary by product line (Biologicals vs. APIs). Please contact our Omani trade desk for a tailored quotation based on your specific requirements.
Absolutely. We have extensive experience providing the technical and financial documentation required for MOH and military hospital tenders in the Sultanate.
We utilize cutting-edge Bio-Fermentation and Co-Crystallization techniques to ensure our intermediates offer superior purity and reaction efficiency.
